The percentage reduction in NT-proBNP also favored SGLT2i use, although the between-group difference did not reach statistical significance ( P = 0.078) (Table 6 ; Fig. 4 ).
← all excerpts
Prognostic impact of SGLT2 inhibitors in acute decompensated heart failure patients stratified by admission systolic blood pressure: a retrospective cohort study.
1
0.0780
0.0780